| Issue Type | Login |
|---|---|
| Country | United States |
| Industry | Login |
| Region | Login |
| Maturity Date | 2035-07-15 |
| Par Value | 1000 |
| Callable | Login |
| Next Call Date | Login |
| Call Type | Login |
| Call Price (%) | Login |
| Series | Login |
| Class | Login |
| Maturity Structure | Login |
| Amount Outstanding (mil) | 288.45 |
| Coupon | 5.25 |
|---|---|
| Coupon Type | Login |
| Coupon Frequency | Login |
| First Coupon Date | Login |
| Last Coupon Date | Login |
| Sinking Fund | Login |
|---|---|
| Security | Login |
| Subordination | Login |
| Debt Type | Login |
| Issue Date | Login |
|---|---|
| Dated Date | Login |
| Issue Size (mil) | 500 |
| Min. Piece | Login |
| Min. Increment | Login |
This Genentech, Inc. corporate note has a 5.25% fixed rate coupon paid on a Login basis. It was issued on MAR 12, 2000 with an issue size of 500.00 million USD and matures on July 15, 2035 with a last coupon date of FEB 28, 2020. |
Genentech, Inc., founded in 1976 and headquartered in South San Francisco, California, is a pioneering biotechnology company dedicated to developing innovative medicines to treat serious medical conditions. The company is renowned for its focus on biologics and has a strong portfolio of targeted therapies for cancer and other diseases, including its flagship products such as Avastin and Herceptin.